Pharmacoeconomic comparison of Helicobacter pylori eradication regimens


SANCAR M., Izzettin F. V. , APIKOGLU-RABUS S., BESISIK F., TOZUN N., DULGER G.

PHARMACY WORLD & SCIENCE, cilt.28, ss.207-214, 2006 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 28 Konu: 4
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1007/s11096-006-9021-y
  • Dergi Adı: PHARMACY WORLD & SCIENCE
  • Sayfa Sayısı: ss.207-214

Özet

Background Helicobacter pylori is the most important etiologic agent for development of peptic ulcer, chronic gastritis and gastric carcinomas. It is now well established that H. pylori eradication treatment is more cost-effective than acid suppressing therapies alone for the treatment of peptic ulcer disease. However, the comparative cost-effectiveness of various H. pylori eradication regimens is still not clear.